Clinical Trials Browser

INDUSTRY × Interventional × etrolizumab × Clear all

NCT02136069 2021-12-03

GARDENIA

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

NCT02165215 2021-08-19

LAUREL

Phase 3 Completed

359 enrolled 34 charts

Colitis, Ulcerative

NCT02100696 2021-08-13

HICKORY

Phase 3 Completed

609 enrolled 52 charts

Colitis, Ulcerative

NCT02163759 2021-07-23

HIBISCUS I

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative